Virtual Symposium: The Evolving Landscape of LDL-C Reduction: Novel Therapies and Approaches

Challenging the Status-Quo: Cardiorenal Protection with SGLT-2 Inhibitors in T2DM and Beyond—Expert Debate and Discussions

Vaccine-Preventable Diseases in the Age of COVID-19: How Can We Keep Them at Bay?

Advances in Influenza Treatment: Optimizing Outcomes in High-Risk Influenza Patients with Chronic Cardiometabolic Conditions

The Emerging Role of Novel GLP-1 RAs in the Management of T2DM: Assessing the Rationale and Evidence

The Changing Landscape of NASH: Navigating Current and Emerging Approaches in Diagnosis and Treatment

Virtual Symposium: Addressing the Unmet Need of Diabetic Kidney Disease Progression: Beyond SGLT-2 Inhibitors and GLP-1 Ras